Taien Kang (301263.SZ): CKBA Cream for Acne Rosacea Conducts Seamless Adaptive Phase II/III Clinical Trials.

The Zhitong Financial APP news, Tiancong (301263.SZ) announced that its holding subsidiary, Jiangsu Bochuangyuan Biomedical Technology Co., Ltd. (referred to as "Bochuangyuan"), has received the "Drug Clinical Trial Approval Notification" issued by the National Medical Products Administration, which approves the seamless adaptive clinical trial of CKBA cream for rosacea indication in Phase II/III.